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Abbreviations 
 
Heterocyclic aromatic amine, HAA; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; 
PhIP-C8-dG, N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; ESI, 
electrospray ionization; LC-MS/MS, liquid chromatography-tandem mass spectrometry (mass 
spectrometry/mass spectrometry); SRM, selected reaction monitoring; CID, collision induced 
dissociation 
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Abstract 
 
The heterocyclic aromatic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is 
formed by the grilled cooking of certain foods such as meats, poultry and fish. PhIP has been 
shown to induce tumours in the colon, prostate and mammary glands of rats and is regarded as a 
potential human dietary carcinogen. PhIP is metabolically activated via cytochrome P450 
mediated oxidation to an N-hydroxylamino-PhIP intermediate that is subsequently converted to 
an ester by N-acetyltransferases or sulfotransferases and undergoes heterolytic cleavage to 
produce a PhIP-nitrenium ion, which reacts with DNA to form the N-(deoxyguanosin-8-yl)-2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP-C8-dG) adduct. Thus far, the detection 
and quantification of PhIP-DNA adducts has relied to a large extent on 32P-postlabelling 
methodologies. In order to expand the array of available techniques for the detection and 
improved quantification of PhIP-C8-dG adducts in DNA we have developed an online column-
switching liquid chromatography (LC)-electrospray ionization (ESI)-tandem mass spectrometry 
(MS/MS) selected reaction monitoring (SRM) method incorporating an isotopically [13C10]-
labelled PhIP-C8-dG internal standard for the analysis of DNA enzymatically hydrolysed to 2'-
deoxynucleosides. A dose-dependent increase was observed for PhIP-C8-dG adducts when 
salmon testis DNA was reacted with N-acetoxy-PhIP. Analysis of DNA samples isolated from 
colon tissue of mice treated by oral gavage daily for 5 days with 50 mg/kg body weight of PhIP 
resulted in the detection of an average level of 14.8 ± 3.7 PhIP-C8-dG adducts per 106 2'-
deoxynucleosides. The method required 50 µg of hydrolysed animal DNA on column and the 
limit of detection for PhIP-C8-dG was 2.5 fmol (1.5 PhIP-C8-dG adducts per 108 2′-
deoxynucleosides). In summary, the LC-ESI-MS/MS SRM method provides for the rapid 
automation of the sample clean up and a reduction in matrix components that would otherwise 
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interfere with the mass spectrometric analysis, with sufficient sensitivity and precision to analyse 
DNA adducts in animals exposed to PhIP. 
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Introduction 
 
The heterocyclic aromatic amine (HAA), 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP) is formed following the pyrolysis of amino acids and reaction with sugars in 
the presence of creatine/creatinine during the grilled cooking of certain foods, such as meats, 
poultry and fish [1-5]. PhIP represents one of the most abundantly formed of more than 20 
HAAs that have been shown to be mutagenic in bacterial assays as well as mammalian cells 
[3,5]. The carcinogenic properties of HAAs have been demonstrated in rodent bioassays 
following long-term feeding studies [6]. PhIP has been found to induce tumours in the colon, 
prostate and mammary glands of rats, which represent the principal sites that are associated with 
human dietary related cancer implying that it could be a human carcinogen [3,4,7-9]. The 
International Agency for Research on Cancer (IARC) has classified PhIP as a group 2B 
carcinogen (possibly carcinogenic to humans) [10]. 
The genotoxicity of PhIP is related to metabolic activation resulting in an electrophilic 
species that is capable of generating covalent DNA adducts [1]. PhIP undergoes an initial 
oxidation step to an N-hydroxylamino-PhIP intermediate which is mediated by cytochrome 
(CYP) P450 enzymes, primarily by CYP1A2 in humans [11-13]. Subsequent metabolism by N-
acetyltransferases (NAT) or sulfotransferases (SULT) converts the N-hydroxylamino-PhIP into 
an ester capable of undergoing heterolytic cleavage to produce a PhIP-nitrenium ion, which is 
the ultimate reactive species that reacts with DNA (Scheme 1) [5,13,14]. The major covalent 
DNA adduct detected in vivo resulting from the exposure of experimental animals and humans to 
PhIP is N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP-C8-
dG) [14,15]. 
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Numerous methods have been developed for the detection of PhIP-derived DNA adducts, which 
include 32P-Postlabelling in combination with thin layer chromatography (TLC) or high 
performance liquid chromatography [16-20], immunological methods [7,9], gas 
chromatography-mass spectrometry following alkaline hydrolysis of PhIP adducts to the parent 
amine [21,22] and accelerator mass spectrometry [23-25]. 32P-Postlabelling has been the most 
widely used method for the detection of PhIP-DNA adducts in animal and human tissues offering 
the advantage that only small amounts of DNA are required for analysis. The development of 
electrospray ionization (ESI) has permitted the coupling of liquid chromatography (LC) to mass 
spectrometry (MS), which has been used for the detection of numerous DNA adducts [26]. LC-
mass spectrometry has made sufficient gains in sensitivity for the detection of DNA adducts 
resulting in it being a viable alternative to other detection methods such as 32P-postlabelling and 
immunoassays, to provide more accurate and precise results through the use of stable isotope 
internal standards [27,28]. Recently, LC-tandem mass spectrometry (MS/MS) methods using 
deuterated stable isotope internal standards and off-line pre-purification of the PhIP-C8-dG 
adduct using solid phase extraction or online column-switching LC have been described for the 
detection and quantitation of adducts in cells and DNA treated in vitro with PhIP, and also in the 
liver and colon of rats treated in vivo with PhIP [20,22,29-31]. Mass spectrometry based methods 
offer a number of advantages with respect to the identification and quantitation of DNA adducts, 
as they rely on the detection of adduct-specific ions and characteristic transitions of the ions 
being monitored, respectively, and because quantification is based upon the use of isotopically-
labelled internal standards. 
We describe the development of a method involving online column-switching LC-
MS/MS using selected reaction monitoring (SRM) for the determination of PhIP-C8-dG in DNA 
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that has been enzymatically hydrolysed to 2'-deoxynucleosides. This newly developed method 
allows for the rapid automation of the sample clean up and a reduction in matrix components that 
would otherwise interfere with the mass spectrometric analysis. We applied this method to the 
detection of PhIP-C8-dG adducts in DNA samples from salmon testis DNA treated with different 
concentrations of N-acetoxy-PhIP in vitro and DNA obtained from mouse colon tissue following 
dosing with PhIP. 
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Experimental Procedures 
 
Chemicals and Reagents 
 
PhIP was acquired from Toronto Research Chemicals (North York, Ontario, Canada), and 
[13C10]-2′-deoxyguanosine was purchased from Cambridge Isotope Laboratories (Andover, MA). 
All other reagents used in the preparation of the DNA adduct standards and in vitro modified 
DNA samples were of the highest available purity and purchased from Sigma-Aldrich (St. Louis, 
MO). Caution: PhIP and its derivatives are mutagens and carcinogens and should be handled 
with care. Protective clothing should be worn and appropriate safety procedures followed when 
working with these compounds. Salmon testis DNA, deoxyribonuclease I (from bovine 
pancreas), snake venom phosphodiesterase I (from Crotalus adamanteus), alkaline phosphatase 
(from E. coli) and mass spectrometry grade formic acid were purchased from Sigma (Poole, 
UK). HPLC grade water, 18.2 MΩcm output quality was obtained from Maxima purification 
equipment (Elga, High Wycombe, UK). All other reagents (analytical grade) and HPLC grade 
acetonitrile were purchased from Fisher Scientific (Loughborough, UK). 
 
Synthesis of N-acetoxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-acetoxy-
PhIP)  
2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-hydroxylamino-PhIP) was 
prepared as described previously, by diazotization of PhIP and reaction with sodium nitrite 
followed by catalytic reduction of the nitro derivative thus obtained with Pd/C to the N-
hydroxylamine. [32] The hydroxylamine was acetylated as described previously to afford N-
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acetoxy-PhIP. [14] Given the expected instability of N-acetoxy-PhIP, it was used without any 
further purification. 
 
Preparation of unlabelled and isotopically labelled N-(deoxyguanosin-8-yl)-2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine adduct standards 
The PhIP-C8-dG adduct standards were prepared as described previously [14], by reacting the 
crude acetylation mixtures containing N-acetoxy-PhIP with solutions of 2′-deoxyguanosine or 
[13C10]-2′-deoxyguanosine. Unlabelled and [13C10]-labelled PhIP-C8-dG thus obtained were 
purified by reverse-phase HPLC [14]. The identity and purity of the unlabelled PhIP-C8-dG was 
confirmed by 1H NMR and ESI-MS/MS (data not shown). The adduct standard solutions were 
quantified by UV spectrophotometry, based upon an extinction coefficient of ε = 33,300 M-1cm-1 
at λmax 360 nm. [22] 
 
Preparation of salmon testis DNA samples modified in vitro with N-acetoxy-2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine 
A range of DNA samples with different levels of in-vitro modification were prepared by 
adding serial 10-fold dilutions of N-acetoxy-PhIP in THF to solutions of salmon testis DNA (1 
mg/mL in 25 mM phosphate buffer, pH 7.0). The estimated concentrations of the N-acetoxy-
PhIP in the reaction mixtures ranged from ca. 0.0001 mg/mL to 0.1 mg/mL. The reaction 
mixtures were incubated overnight at 37ºC, extracted with 1 volume of ethyl acetate then 1 
volume of water-saturated n-butanol, and then DNA was precipitated by addition of 0.1 volume 
of 5 M NaCl and 2 volumes of ice-cold ethanol. DNA samples were centrifuged, the pellets thus 
obtained were washed twice with 5 mL of ice-cold ethanol/water (70:30, v/v) and the residues 
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finally obtained upon centrifugation were redissolved in 5 mM BisTris buffer, pH 7.1, 0.1 mM 
EDTA, allowing an overnight rehydration at 4ºC before freezing the samples at −80ºC until 
further use. The DNA concentrations in the final solutions were determined by UV 
spectrophotometry. 
 
Enzymatic hydrolysis of in vitro modified salmon testis DNA for LC-ESI-MS/MS analysis  
Each of the in vitro modified salmon testis DNA samples (400 µg) was evaporated to 
dryness using a centrifugal vacuum evaporator. The dried DNA samples were dissolved in 990 
µL of 50 mM BisTris, 0.1 mM EDTA, pH 7.1 buffer plus 10 µL of 1 M MgCl2 and incubated 
with 100 µL of deoxyribonuclease I (2 mg/mL dissolved in 0.15 M NaCl, 10 mM MgCl2) at 
37ºC for 6 h. The samples were further incubated with 80 µL of snake venom phosphodiesterase 
I from Crotalus adamanteus (0.001 U/µL dissolved in 0.11 M Tris-HCl, 0.11 M NaCl, 15 mM 
MgCl2, pH 8.9) and 26.2 µL of alkaline phosphatase from E. coli (0.305 U/µL) at 37ºC for 15 h. 
The hydrolysed DNA samples were centrifuged at 14,000 rpm for 1 min and the supernatants 
transferred to new microfuge tubes for storage at −80ºC. Aliquots of the hydrolysed DNA 
samples were removed to which were added 1333.3 fmol of the [13C10]-labelled PhIP-C8-dG 
internal standard (100 fmol/µL) and evaporated to dryness using a centrifugal vacuum 
evaporator. The dried samples were dissolved in 20 µL of HPLC grade water/methanol (80:20, 
v/v), centrifuged at 14,000 rpm for 2 min and transferred to HPLC vials with low volume inserts. 
A 15 µL aliquot of each sample was injected on to the online column switching LC-ESI-MS/MS, 
equivalent to 5 or 10 µg of hydrolysed DNA depending on the extent of modification by PhIP 
with 1000 fmol of the [13C10]-labelled PhIP-C8-dG internal standard on column. 
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Treatment of animals  
Porlox/lox/CreCYP1A1 mice on a C57BL/6 background (Reductase Inducible Cre, RIC) were 
bred in-house at the Biomedical Research Institute, Dundee [33]. In these mice the cytochrome 
P450 oxidoreductase (Por) gene can be deleted tissue-specifically after the administration of 
chemical inducers (e.g. 3-methylcholanthrene) of CYP1A1. However, in the absence of the 
chemical inducer (as in the present study), these mice are phenotypically normal and 
indistinguishable from wild-type animals. Adult female RIC mice, > 3 weeks old, were dosed by 
oral gavage daily for 5 days with 50 mg/kg body weight of PhIP dissolved in corn oil. Control 
animals were dosed with corn oil alone. Animals were sacrificed and the colon tissue was 
removed. DNA isolation was performed by using standard phenol/chloroform extraction. All 
animal experiments were carried out under license in accordance with the law, and following 
local ethical review. 
 
Enzymatic hydrolysis of animal DNA for LC-ESI-MS/MS analysis 
Prior to enzymatic digestion 1333.3 fmol of the [13C10]PhIP-C8-dG internal standard (100 
fmol/µL) was added to 66.7 µg of the mouse DNA samples and evaporated to dryness using a 
centrifugal vacuum evaporator. The dried DNA samples were dissolved in 99 µL of 50 mM 
BisTris, 0.1 mM EDTA, pH 7.1 buffer plus 1.0 µL of 1 M MgCl2 and incubated with 10 µL of 
deoxyribonuclease I (2 mg/mL dissolved in 0.15 M NaCl, 10 mM MgCl2) at 37ºC for 6 h. The 
samples were further incubated with 6.0 µL of snake venom phosphodiesterase I from Crotalus 
adamanteus (0.001 U/µL dissolved in 0.11 M Tris-HCl, 0.11 M NaCl, 15 mM MgCl2, pH 8.9) 
and 3.18 µL of alkaline phosphatase from E. coli (0.315 U/µL) at 37ºC for 15 h. The hydrolysed 
DNA samples were centrifuged at 14,000 rpm for 2 min and the supernatant transferred to a new 
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eppendorf tube and then evaporated to dryness using a centrifugal vacuum evaporator. The dried 
samples were dissolved in 20 µL of HPLC grade water/methanol (80:20, v/v) and transferred to 
HPLC vials with low volume inserts. A 15 µL aliquot of each sample, equivalent to 50 µg of 
hydrolysed DNA and 1000 fmol of the [13C10]PhIP-C8-dG internal standard on column was 
injected on to the online column switching LC-ESI-MS/MS. 
 
Online column-switching LC-ESI-MS/MS analysis 
The online column switching valve system consisted of an automated switching valve 
(motorized two-position six-port valve, Waters Ltd., Hertfordshire, UK) connected to pump A 
incorporating an autosampler (Waters Alliance 2695 separations module with a 100 µL injection 
loop) and an isocratic pump B (Gynotek GmbH, Germering, Germany). Pump A was connected 
via the switching valve to the trap column, a Synergi Fusion-RP 80A C18, 4 µm, 30 × 2.0 mm 
column attached to a KrudKatcher disposable pre-column (0.5 µm) filter (Phenomenex, 
Macclesfield, UK) and Pump B was connected via the switching valve to the analytical column, 
a Synergi Fusion-RP 80A C18 (4 µm, 250 × 2.0 mm) column attached to a Synergi Fusion-RP 
80A C18 (4 µm, 4.0 × 2.0 mm) guard column and KrudKatcher disposable pre-column (0.5 µm) 
filter. The outlet of the analytical column was directly connected to the mass spectrometer. The 
configuration of the online column switching valve system is summarised in Figure 1. 
Sample loading: A 15-µL aliquot of the in vitro modified (equivalent to 5 or 10 µg of 
hydrolysed DNA) or animal (equivalent to 50 µg of hydrolysed DNA) DNA sample containing 
1000 fmol of [13C10]PhIP-C8-dG internal standard was injected onto the trap column using pump 
A with the switching valve in position 1. The impurities on the trap column were eluted to waste 
using a gradient with solvent A, 0.1% formic acid/HPLC grade water (0.1:99.9, v/v) and solvent 
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B, 0.1% formic acid/acetonitrile (0.1:99.9, v/v) at a flow rate of 120 µL/min. The following 
gradient was used: 0 min–15%B, 5 min–15%B, 15 min–65%B, 24 min–65%B, 24.1 min–15%B, 
40 min–15%B. Concurrently isocratic flow at 120 µL/min via the analytical column, which was 
eluted with 0.1% formic acid/acetonitrile (0.1% formic acid) (75:25, v/v), was maintained to the 
mass spectrometer by means of pump B. 
Sample elution: At 12.0 min the switching valve was switched to position 2 allowing the 
purified PhIP-C8-dG adduct to be back-flushed from the trap column onto the analytical column 
and then subsequent elution into the mass spectrometer. The isocratic flow was maintained by 
pump B at flow rate of 120 µL/min with 0.1% formic acid/ acetonitrile (0.1% formic acid) 
(75:25, v/v) for 12.0 min. Concurrently the flow from pump A bypassed the trap column and was 
diverted directly to waste. At 24.0 min the switching valve was switched back to position 1 and 
the configuration of the online column switching system reverted back to initial conditions as 
described for the sample loading above. The total run time was 40 min. 
Mass spectrometry: A Waters Micromass Quattro Ultima Pt (Micromass, Waters Ltd., 
Manchester, UK) tandem quadrupole mass spectrometer with an electrospray interface was used. 
The temperature of the electrospray source was maintained at 120ºC and the desolvation 
temperature at 350ºC. Nitrogen gas was used as the desolvation gas (650 L/h) and the cone gas 
(25 L/h). The capillary voltage was set at 3.20V. The cone and RF1 lens voltages were 42 V and 
15 V, respectively. The collision gas was argon (indicated cell pressure 2.0 × 10-3 mbar) and the 
collision energy set at 12 eV. The dwell time was set to 200 ms and the resolution was two m/z 
units at peak base. The mass spectrometer was tuned by using a standard solution of PhIP-C8-dG 
(10 pmol/µL) in 0.1% formic acid/acetonitrile (0.1% formic acid) (75:25, v/v) introduced by 
continuous infusion at a flow rate of 10 µL/min with a Harvard model 22 syringe pump (Havard 
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Apparatus Ltd., Edenbridge, UK). The hydrolysed DNA samples were analysed in positive ESI 
MS/MS selected reaction monitoring (SRM) mode for the [M+H]+ ion to base [B+H2]+ 
transitions of m/z 490 to 374 for PhIP-C8-dG and m/z 500 to 379 for [13C10]PhIP-C8-dG. The 
level of the adduct in the DNA samples was determined from the ratio of peak area of the 
[13C10]PhIP-C8-dG internal standard.  
 
Calibration curve for PhIP-C8-dG adducts with DNA matrix 
The calibration curvess were constructed by the addition of different amounts of the 
unlabelled PhIP-C8-dG standards (ranging from 2.0 to 4000 fmol) plus 1000 fmol of the 
[13C10]PhIP-C8-dG internal standard to 50 µg of enzymatically hydrolysed calf thymus DNA as 
the matrix. The standards were subjected to the online column switching LC-ESI-MS/MS 
analysis procedure as described above. 
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Results 
Validation of the online column switching LC-ESI-MS/MS analysis 
Accurate DNA adduct quantitation by mass spectrometry is best achieved by coupling 
selected reaction monitoring (SRM) with the use of stable isotope-labelled internal standards. 
Mass spectrometric analysis of the [13C10]PhIP-C8-dG internal standard was performed in 
positive mode LC-ESI-MS/MS using the trap column only and resulted in a typical product ion 
spectrum that is normally observed for adducted 2′-deoxynucleosides following the neutral loss 
(121 u) of the [13C5]-labelled 2′-deoxyribose moiety. The 13C-labelled atoms were equally 
distributed between the adducted base and 2′-deoxyribose moiety of the molecule as shown in 
Figure 2. The collision induced dissociation (CID) product ion mass spectrum consisted of the 
adducted base as being the most abundant product ion formed from the [M+H]+ ion at m/z 500. 
The adducted base product ion [B+H2]+ at m/z 379 was formed by the cleavage of the glycosidic 
bond and the accompanied proton transfer from the 2′-deoxyribose moiety to the adducted base 
(Figure 2). A similar fragmentation pattern with the m/z decreased by 5 for the adducted base 
product ion [B+H2]+ was observed for the corresponding unlabelled PhIP-C8-dG standard 
[M+H]+ ion. [13C10]PhIP-C8-dG was chemically pure as determined by HPLC-UV and no 
unlabelled adduct was detectable in the isotopic standard solutions as determined by LC-ESI-
MS/MS SRM. 
Initial experiments involved optimisation of the mobile phase conditions for the 
separation of the PhIP-C8-dG adduct on the trap column from unmodified 2'-deoxynucleosides 
and matrix impurities. A gradient mobile phase system consisting of 0.1% formic acid and 
acetonitrile (0.1% formic acid) was found to give the optimal separation on the trap column with 
a retention time of 14.16 min for PhIP-C8-dG. The online column switching valve system was 
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configured as shown in Figure 1 and the switching valve was switched to position 2 at 12.0 min 
following injection of the hydrolysed DNA sample. This allowed for unmodified 2′-
deoxynucleosides plus any other matrix impurities that may have been present to be eluted to 
waste while the PhIP-C8-dG adduct was back-flushed onto the analytical column for analysis by 
the mass spectrometer. 
A typical online column-switching LC-MS/MS calibration curve for the detection of 
PhIP-C8-dG is shown in Figure 3. The calibration curve was obtained by adding different 
amounts of the PhIP-C8-dG standard with 1000 fmol of the [13C10]PhIP-C8-dG internal standard 
to 50 µg of enzymatically hydrolysed calf thymus DNA to account for any matrix effects.. A 
linear response over the range from 2.5 to 4000 fmol, corresponding to 1.5 to 2,469.1 adducts per 
108 2′-deoxynucleosides (Figure 3), was obtained for the detection of PhIP-C8-dG with a 
correlation coefficient (r) of 0.9998 (y = 0.001x-0.0008). The limit of detection on column of the 
method was 2.5 fmol (S/N = 3) corresponding to 1.5 PhIP-C8-dG adducts per 108 2′-
deoxynucleosides and the lower limit of quantitation was 10.0 fmol (S/N = 8) obtained by 
spiking the PhIP-C8-dG adduct and the labelled internal standard into calf thymus DNA (50 µg) 
enzymatic hydrolysate. The intra- and inter-assay coefficients of variation of the online column-
switching LC-ESI-MS/MS method, which were obtained following the analysis of calf thymus 
spiked with 25, 100 and 1000 fmol of the PhIP-C8-dG standard are shown in Table 1. The 
average accuracy of the method, determined by spiking known amounts (2.5 to 4000 fmol) of the 
PhIP-C8-dG adduct and 1000 fmol of the [13C10]PhIP-C8-dG internal standard in calf thymus 
DNA enzymatic hydrolysate was 100.2%. 
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Online column switching LC-ESI-MS/MS analysis of in vitro modified and animal DNA 
samples 
 
Salmon testis DNA was incubated at 37 °C overnight with solutions of N-acetoxy-PhIP. 
The typical online column-switching LC-MS/MS SRM ion chromatograms obtained for the 
determination of PhIP-C8-dG adducts in control (untreated) DNA and salmon testis DNA treated 
with 0.001mg/mL of N-acetoxy-PhIP are shown in Figure 4A and B, respectively. A linear 
dose-dependent increase was observed for the levels of PhIP-C8-dG adducts detected in salmon 
testis DNA following exposure to levels of N-acetoxy-PhIP ranging from 0.0001 to 0.1 mg/mL 
(Figure 5). The levels of PhIP-C8-dG adducts observed for the different DNA samples and the 
intra- and inter-assay coefficients of variation for the analyses are shown in Table 2. The typical 
online column-switching LC-MS/MS ion chromatograms obtained for a mouse colon DNA 
sample is shown in Figure 4C for a control animal that was treated with the vehicle (corn oil) 
alone and Figure 4D shows the typical ion chromatogram obtained following the daily oral 
dosing of a mouse with 50 mg/kg body weight of PhIP for 5 days. The average level of PhIP-C8-
dG adducts detected in colon DNA from three animals treated under these conditions was 14.8 ± 
3.7 PhIP-C8-dG adducts per 106 2'-deoxynucleosides. 
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Discussion 
In the present study we have described the development of an online column-switching 
LC-ESI-MS/MS SRM method that is suitable for the routine detection and quantification of 
PhIP-derived DNA adducts formed in vivo. Mass spectrometry offers great potential when 
applied to the detection and quantification of DNA adducts due to its very high sensitivity and 
chemical specificity, which allows the identification of specific DNA adducts in complex 
biological matrices. The advantage of using online column-switching LC is that an enzymatically 
hydrolysed DNA sample can be analysed directly without the requirement for off-line pre-
purification such as solid phase extraction of the DNA adduct, from the vast excess of 
unmodified 2′-deoxynucleosides that could potentially interfere with the analysis. The PhIP-C8-
dG adduct is retained on a trap (enrichment) column while unmodified 2′-deoxynucleosides are 
eluted to waste. Following elution of the unmodified 2′-deoxynucleosides as well as any matrix 
impurities that may cause concomitant ionisation suppression, the switching valve diverts the 
flow from the trap column into the analytical column, which is connected to the mass 
spectrometer. We have previously applied a similar approach for the determination of DNA 
adducts derived from reactive oxygen species, acetaldehyde and 3-nitrobenzanthrone [28,34,35]. 
Interferences from the matrix may result in poor sensitivity by competition for charge, or 
increased droplet viscosity and surface tension from high concentrations of co-eluting interfering 
compounds for the formation of gas phase ions in the electrospray source [36]. The addition of 
[13C10]PhIP-C8-dG internal standard prior to enzymatic hydrolysis of the DNA samples allowed 
for the accurate quantification of the adduct and also provided confirmation of the identity of the 
analyte peak since it eluted at the identical retention time as the unlabelled PhIP-C8-dG. The 13C-
labelled stable isotope internal standard affords the advantage, when compared to deuterium 
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labelled internal standards, that it is not subject to isotope (eg. deuterium-hydrogen) exchange. 
Furthermore the fragmentation properties of deuterated compounds may be different from the 
corresponding natural isotope abundance containing compounds due to the more stable nature of 
the C-D covalent bond in relation to the C-H bond. Therefore, the accurate quantitation of the 
analyte may require the determination of a response factor to correct for this difference in 
fragmentation [37]. For both the PhIP-C8-dG adduct and the corresponding stable isotope 
internal standard SRM transitions were used for the [M+H]+ ion to adducted base product ion 
[B+H2]+ formed by the cleavage of the glycosidic bond. SRM offers the greatest sensitivity due 
to decreased solvent and matrix interferences, and increased specificity due to the monitoring of 
a characteristic fragmentation following CID of the compound being investigated. Initial method 
validation was performed by the construction of calibration curves following the spiking of 
PhIP-C8-dG into calf thymus DNA within a range of 2.5 to 4000 fmol. The method presented 
good statistical performance with average intra- and inter-assay coefficients of variation of 4.9 
and 5.6%, respectively. The estimated LOD and LOQ was 2.5 and 10 fmol on column for PhIP-
C8-dG, respectively. These values correspond to a LOD and LOQ of 1.5 and 6.2 PhIP-C8-dG 
adducts per 108 deoxynucleosides in a 50 µg DNA sample, respectively. 
In order to develop the online column-switching LC-ESI-MS/MS method for the 
detection and quantification of PhIP derived DNA adducts formed in vivo, salmon testis DNA 
samples were treated with different concentrations of the reactive metabolite N-acetoxy-PhIP 
ranging from 0.0001 to 0.1 mg/mL. A dose-dependent increase was observed for PhIP-C8-dG 
adducts following reaction of salmon testis DNA with N-acetoxy-PhIP. The levels ranged from 
5.5 to 2728.2 PhIP-C8-dG adducts per 106 2′-deoxynucleosides. The average intra- and inter-
assay coefficients of variation for the analysis of these samples were 3.3 and 5.3%, respectively. 
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Analysis of DNA samples isolated from colon tissue of mice treated by oral gavage daily for 5 
days with 50mg/kg body weight of PhIP resulted in the detection of an average level of 14.8 ± 
3.7 PhIP-C8-dG adducts per 106 2'-deoxynucleosides. No PhIP-C8-dG adducts were detected in 
control animals dosed with corn oil alone. Previous studies have shown higher levels of PhIP-
C8-dG adducts are detected in colon tissue when compared to the liver, which is consistent with 
the colon being the target tissue for tumour development [29,30]. 
In the past detection and quantification of PhIP DNA adducts has relied to a large extent 
on the 32P-postlabelling technique [16-18]. The limitations of 32P-postlabelling are that it does 
not provide structural confirmation of the adduct being detected and lacks the incorporation of an 
internal standard to account for adduct recovery and labelling efficiencies. Furthermore 32P-
postlabelling of HAA-DNA adducts has resulted in considerable inter-laboratory variation in the 
patterns of adduct spots detected following TLC separation making the interpretation of the 
results very difficult. It has been suggested that the majority of the additional spots observed 
correspond to adducted oligonucleotides as consequence of partial enzymatic hydrolysis of the 
DNA [16]. The online column-switching LC-ESI-MS/MS SRM method described here would 
require higher amounts of DNA for the analysis of human samples exposed to dietary levels of 
PhIP and is generally less sensitive when compared to 32P-postlabelling methods. However, it 
presents the clear advantages of providing accurate quantitation with information on the 
chemical identity of the adduct and constitutes a more automated and faster analytical method. 
Presently accelerator mass spectrometry represents the most sensitive method for the detection of 
DNA adducts at levels normally encountered in human biomonitoring studies and allows dosing 
with HAAs at dose levels comparable to those found in the diet [23-25]. However the technique 
is disadvantaged by the requirement of dosing with 3H- or 14C-labelled carcinogens which is not 
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amenable for general human population based studies and does not provide any structural 
information [23-25]. The use of capillary- or nano-LC coupled to micro- or nanoelectrospray 
ionisation mass spectrometry in theory should provide for improvements in sensitivity and allow 
the detection of PhIP-C8-dG adducts in animal and human samples following dietary levels of 
exposure to PhIP. 
In conclusion, we have developed an online column-switching LC-ESI-MS/MS SRM 
method with sufficient sensitivity and precision for the analysis of PhIP-C8-dG adducts formed 
in in-vitro experiments and in-vivo animal studies. 
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Legends 
 
 
Scheme 1 Bioactivation of PhIP and DNA adduct formation. 
 
Figure 1 Schematic representation of the online column-switching system. 
 
Figure 2 Positive LC-ESI-MS/MS CID product ion spectrum of the [13C10]PhIP-C8-dG internal 
standard. The spectrum was acquired following gradient elution of the trap column with solvent 
A, 0.1% formic acid and solvent B, acetonitrile (0.1% formic acid) at a flow rate of 120 µL/min 
(the asterisks indicate the 13C labelled sites) 
 
Figure 3 Online column-switching LC-MS/MS SRM calibration curve for the detection of PhIP-
C8-dG (error bars represent the standard deviation, n = 3). The ratio of the peak area of the PhIP-
C8-dG standard to that of the [13C10]PhIP-C8-dG internal standard spiked into 50 µg on column 
of calf thymus DNA subjected to enzymatic hydrolysis was plotted against the amount of the 
PhIP-C8-dG (fmol). The inset shows the expanded view of the calibration curve at the lower 
levels of PhIP-C8-dG. 
 
Figure 4 Typical online column-switching LC-MS/MS SRM ion chromatograms for the 
determination of PhIP-C8-dG in (A) control calf thymus DNA (B) following the treatment of 
salmon testis DNA with 0.001 mg/mL of N-acetoxy-PhIP (C) colon DNA from mouse dosed 
with corn oil and (D) colon DNA from mouse treated with 50 mg/kg body weight of PhIP (50 µg 
of hydrolysed DNA was analysed (for (B) 10µg) and 1000 fmol of [13C10]PhIP-C8-dG internal 
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standard on column). The SRM transitions monitored were m/z m/z 490 to 374 for PhIP-C8-dG 
and m/z 500 to 379 for [13C10]PhIP-C8-dG. The trap column was eluted using a gradient with 
solvent A, 0.1% formic acid and solvent B, acetonitrile (0.1% formic acid) at a flow rate of 120 
µL/min. The analytical column was eluted isocratically with 0.1% formic acid/acetonitrile (0.1% 
formic acid) (75:25, v/v) at a flow rate of 120 µL/min. 
 
Figure 5 Plot for the formation of PhIP-C8-dG adducts following the treatment of salmon testis 
DNA with N-acetoxy-PhIP concentrations ranging from 0.0001 to 0.1 mg/mL as determined by 
online column-switching LC-MS/MS SRM analysis. 
 
 
Table Legends 
 
Table 1 Intra- and inter-assay precision for the determination of PhIP-C8-dG spiked into calf 
thymus DNA (50 µg of enzymatically hydrolysed DNA on column) 
a and b
 n = 4 and 4, respectively 
 
 
Table 2 Determination of PhIP-C8-dG adducts in salmon testis DNA treated with PhIP using 
online column-switching LC-MS/MS SRM analysis.  
a and b
 10 and 5 µg of enzymatically hydrolysed DNA analysed on column, respectively 
c
 the ± error represents the standard deviation (n = 3) 
d
 n = 3 
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